I

Immunocore

443 employees

Immunocore is a biotechnology company that specializes in the development of TCR bispecific immunotherapies.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
biologics
hiring
autoimmune
jobs
t-cells
ImmTacs
Pharmaceutical
oncology
Health Care
infectious disease
scientists
regulatory affairs
ImmunoOncology
CMC
immune system
Medical
Biotechology

Date founded

2008

Funding rounds raised

Total raised

$320M

from 11 investors over 11 rounds

I

Immunocore raised $140M on July 18, 2022

Investors: RTW Investments, LP and General Atlantic

I

Immunocore raised $100M on January 11, 2021

Investors: Oxford Finance LLC

I

Immunocore raised $130M on March 2, 2020

Investors: JDRF T1D Fund, General Atlantic, RTW Investments, LP, WuXi AppTec and Bill & Melinda Gates Foundation

I

Immunocore raised $40M on September 18, 2017

Investors: Bill & Melinda Gates Foundation

I

Immunocore raised $320M on July 16, 2015

Investors: RTW Investments, LP and Woodford Investment Management

FAQ